Oxygen Advantage / Buteyko

Oxygen Advantage is a science-based breathwork training company founded by Patrick McKeown, headquartered in Galway, Ireland. The company operates two primary training methodologies: the Buteyko Clinic International program, which addresses respiratory conditions, sleep disorders, and anxiety through breathing re-education, and the Oxygen Advantage method, which optimizes breathing for performance and mental clarity in healthy individuals. Both programs teach evidence-based breathing techniques designed to improve oxygen efficiency, CO2 tolerance, and nervous system regulation across clinical practice, rehabilitation, and peak performance contexts.

The company's approach centers on the principle that breathing patterns directly influence respiratory function, mental clarity, and overall well-being. Rather than selling consumer devices, Oxygen Advantage primarily operates as a training and certification organization, empowering healthcare professionals, coaches, and instructors to deliver measurable breathing improvements to their clients. The company also produces products like Myotape to support nasal breathing optimization.

Clinical evidence supports the Buteyko Method's effectiveness: studies show 70% reduction in asthma symptoms, 90% reduction in rescue medication need, and 49% reduction in steroid inhaler use. The methodology addresses specific conditions including asthma, sleep apnea, dysfunctional breathing, anxiety, panic disorder, and children's breathing development, making it applicable across diverse health scenarios.